Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Peter Carlin is EVP and CFO at Adient. OQRO lists 3 transactions filed with the SEC under this name, the latest on Nov 17, 2026, each linked to the official Form 4.
EVP and CFO
Disclosures on record
3
Companies involved
1
AdientADNT
3 disclosures · Mar 2026 – Nov 2026 · 1 sold
Nov 16, 2026210Kdisclosed Nov 17
DetailsOfficial recordSep 2, 2026Sold~$151Kdisclosed Sep 4
DetailsOfficial recordMar 10, 20268,208disclosed Mar 12
DetailsOfficial recordAs of the latest filing on , Peter Carlin reported holding 249,231 shares of Adient (ADNT), worth about $3.75M at the last close of $15 (Nov 17, 2026). In the last 12 months, Peter Carlin sold $151K in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Adient ADNT | 249,231 | 249K direct | $15 | $3.75M | Nov 16, 2026 |
Is this Peter Carlin’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Peter Carlin has no open-market purchase on record since 2022. Sales in 4 of the 5 years since 2022.
Peter Carlin reported 0 open-market purchases and 4 sales since 2022; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $151K1×1 trade |
| 2024 | — | $122K1×1 trade |
| 2023 | — | $119K1×1 trade |
| 2022 | — | $79K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 16, 2026, Peter Carlin reported holding 249,231 shares of Adient (ADNT). At the last close of $15 on Nov 17, 2026, that is about $3.75M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Peter Carlin reported 1 open-market sale worth $151K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Peter Carlin has no open-market purchase on record since 2022. Sales in 4 of the 5 years since 2022.
In SEC filings since 2022: no open-market purchase is on record; the latest open-market sale is from 2026.
Adient (ADNT), from 2022 to 2026: 0 purchases and 4 sales.
Peter Carlin reported 0 open-market purchases and 4 sales here, 2022 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.